Synapse - Andrew Zelenetz

Search Within

Andrew D Zelenetz

Results (785)

Reply to A. Hüttmann et al

Journal Article

Moskowitz, C. H.; Zelenetz, A. D.; Schoder, H.
Journal of Clinical Oncology (2010)

High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper

Journal Article

Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
British Journal of Haematology (2010)

Fulltext@MSK | Save

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Journal Article

Moskowitz, A. J.; Yahalom, J.; Kewalramani, T.; Maragulia, J. C.; Vanak, J. M.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2010)

Fulltext@MSK | Save

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma

Journal Article

Moskowitz, C. H.; Schoder, H.; Teruya-Feldstein, J.; Sima, C.; Iasonos, A.; Portlock, C. S.; Straus, D.; Noy, A.; Palomba, M. L.; O'Connor, O. A.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Prognostic value of quantitative image analysis (QIA) for determination of proliferative index in mantle cell lymphoma (MCL) treated with sequential chemotherapy followed by high-dose therapy and autologous stem cell rescue (HDT/ASCR)

Meeting Abstract

Schaffel, R.; Hedvat, C.; Teruya-Feldstein, J.; Portlock, C. S.; Moskowitz, C. H.; Zelenetz, A. D.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma

Meeting Abstract

Caces, D. D.; Halaas, J.; Hamlin, P.; Noy, A.; Kewalramani, T.; Portlock, C. S.; Zelenetz, A. D.; O'Connor, O. A.; Gerecitano, J. F.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): Final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas

Meeting Abstract

Gerecitano, J.; Portlock, C. S.; Hamlin, P. A.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Schulman, P.; Dumitrescu, O.; Sarasohn, D.; Pappanicholaou, J.; more...
Blood (2009)

Fulltext@MSK | Save

Negative interim FDG-PET scan is predictive of superior outcome in T cell lymphoma

Meeting Abstract

Casulo, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.
Blood (2009)

Fulltext@MSK | Save

The prognostic value of residual FDG-avidity prior to allogeneic stem cell transplantation for lymphoma

Meeting Abstract

Sauter, C. S.; Barker, J. N.; Zelenetz, A. D.; Fleming, S. E.; Castro-Malaspina, H.; Moskowitz, C. H.
Blood (2009)

Fulltext@MSK | Save

Prognostic significance or positron emission tomography (FDG-PET) at baseline and after 4 cycles of R-CHOP in 75 patients with mantle cell lymphoma treated with intensive chemotherapy and autologous stem cell rescue

Meeting Abstract

Schaffel, R.; Moskowitz, C. H.; Maragulia, J. C.; Portlock, C. S.; Hedvat, C. V.; Zelenetz, A. D.
Blood (2009)

Fulltext@MSK | Save